Drug Data Standardization
Drug Data Standardization is a systematic framework that establishes uniform formats, terminologies, and protocols for representing drug-related information to ensure consistency, interoperability, and accuracy across diverse drug databases.
23
Publications
802
Citations
109
Authors
43
Institutions
Publications per year
2017–2026
8
Parents
23
1–5 of 23
109
2
h-index
2
h-index
1
h-index
1
h-index
1 publications · 11 citations
1
h-index
1–5 of 109
43
United States Food and Drug Administration
Silver Spring, United States
3 h-index
9 publications
172 citations
Leiden University
Leiden, The Netherlands
2 h-index
5 publications
1.3K citations
Critical Path Institute
Tucson, United States
2 h-index
12 publications
289 citations
Center for Drug Evaluation and Research
Silver Spring, United States
2 h-index
7 publications
122 citations

Diana Princess of Wales Hospital
Grimsby, United Kingdom
1 h-index
5 publications
80 citations

Ss. Cyril and Methodius University in Skopje
Skopje, North Macedonia
1 h-index
2 publications
68 citations
Pfizer (United States)
New York, United States
1 h-index
1 publications
25 citations

Institute of Cancer Research
London, United Kingdom
1 h-index
4 publications
96 citations
1–8 of 43
Repository · 2 publications · 46 citations
2
h-index
1 publications · 14 citations
1
h-index
1 publications · 25 citations
1
h-index
1 publications · 14 citations
1
h-index
MJA · 1 publications · 21 citations
1
h-index
1–5